Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for t…
Insiders
Transactions
Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
---|---|---|---|---|---|---|---|
$653,224
i
cs
10% Holder
|
12/03/24 |
P
|
200,000 x $1.57 = $314,000.00 |
Footnotes
#1 Represents shares purchased by the reporting person from Jack Schuler, a member of the issuer's board of directors, in a private transaction.
#2 The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.
|
|||
RelevantBeneficialStockOwner object (253) |
$8,310,388
i
cs
10% Holder
|
12/03/24 |
S
|
200,000 x $1.57 = $314,000.00 |
Footnotes
#1 Represents shares sold by the reporting person to John Patience, a member of the issuer's board of directors, in a private transaction for tax planning purposes.
#2 The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the trust.
|
||
RelevantBeneficialStockOwner object (253) |
$20,225
d
cs
10% Holder
|
06/28/24 |
M
|
4,737 x $0 = $0 |
Footnotes
#1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
|
||
$33,558
d
cs
10% Holder
|
06/28/24 |
M
|
4,737 x $0 = $0 |
Footnotes
#1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
|
|||
$36,891
d
cs
10% Holder
|
06/28/24 |
M
|
4,737 x $0 = $0 |
Footnotes
#1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
|
Get PRO Today
With PRO you will unlock 50 more insider transactions for Accelerate Diagnostics, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Black Mark S. Director
- Burris Wayne Director
- Francesconi Louise Director
- Massarany Hany Director
- Mertz Larry Michael Chief Technology Officer
- Ogilvie Marran H. Director
- Patience David Chief Financial Officer
- Patience John Director
- Phillips Jack Chief Executive Officer
- Regan Jennifer Director
- Strobeck Matthew Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Black Mark S. Director
- Burris Wayne Director
- Francesconi Louise Director
- Massarany Hany Director
- Mertz Larry Michael Chief Technology Officer
- Ogilvie Marran H. Director
- Patience David Chief Financial Officer
- Patience John Director
- Phillips Jack Chief Executive Officer
- Regan Jennifer Director
- Strobeck Matthew Director